Literature DB >> 15751005

Proteomic study of human hepatocellular carcinoma using two-dimensional difference gel electrophoresis with saturation cysteine dye.

Kazuyasu Fujii1, Tadashi Kondo, Hideki Yokoo, Tesshi Yamada, Keiji Iwatsuki, Setsuo Hirohashi.   

Abstract

To identify the proteomic alterations associated with carcinogenesis of hepatocellular carcinoma (HCC), we compared the protein expression profiles of nine HCC cell lines with those of primary cultured hepatocytes established from five individuals. A differential proteomic study was performed by two-dimensional difference gel electrophoresis, in which protein samples are labeled with different fluorescent dyes and separated according to their isoelectric point and molecular weight. To label the protein samples, we used a newly developed and highly sensitive fluorescent dye, which reacts with all reduced cysteine residues of proteins. Principal component analysis based on the intensity of 1238 protein spots indicated that the HCC cells and the normal hepatocytes had distinct proteomic profiles. The Wilcoxon test was used to determine the protein spots whose intensity was differentially regulated in the HCC cells compared with the normal hepatocytes, and mass spectrometric analysis was used to identify the proteins corresponding to the spots. The proteins identified are involved in cell cycle regulation, binding to a tumor-suppressor gene product, fatty acid binding, and regulation of translation. Western blotting with specific antibodies revealed the overexpression of PCNA, EB1 and E-FABP in HCC tissues compared with noncancerous tissues. Aberrant regulation of EB1 and E-FABP has not previously been implicated in the development of HCC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15751005     DOI: 10.1002/pmic.200401004

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  23 in total

1.  The microtubule-associated protein EB1 maintains cell polarity through activation of protein kinase C.

Authors:  Joseph M Schober; Guim Kwon; Debbie Jayne; Jeanine M Cain
Journal:  Biochem Biophys Res Commun       Date:  2011-11-19       Impact factor: 3.575

2.  Can proteomics lead to the discovery of real biomarkers for HCC?

Authors:  Yasuhiro Kuramitsu
Journal:  World J Hepatol       Date:  2010-02-27

3.  Differential liver protein expression during schistosomiasis.

Authors:  Marina Harvie; Thomas William Jordan; Anne Camille La Flamme
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

4.  EB1 levels are elevated in ascorbic Acid (AA)-stimulated osteoblasts and mediate cell-cell adhesion-induced osteoblast differentiation.

Authors:  Sofia Pustylnik; Cara Fiorino; Noushin Nabavi; Tanya Zappitelli; Rosa da Silva; Jane E Aubin; Rene E Harrison
Journal:  J Biol Chem       Date:  2013-06-05       Impact factor: 5.157

Review 5.  Drugs that target dynamic microtubules: a new molecular perspective.

Authors:  Richard A Stanton; Kim M Gernert; James H Nettles; Ritu Aneja
Journal:  Med Res Rev       Date:  2011-03-04       Impact factor: 12.944

6.  EB1 promotes Aurora-B kinase activity through blocking its inactivation by protein phosphatase 2A.

Authors:  Lei Sun; Jinmin Gao; Xin Dong; Min Liu; Dengwen Li; Xingjuan Shi; Jin-Tang Dong; Xianyu Lu; Chunyong Liu; Jun Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-13       Impact factor: 11.205

7.  A novel cutaneous Fatty Acid-binding protein-related signaling pathway leading to malignant progression in prostate cancer cells.

Authors:  Zhengzheng Bao; Mohammad I Malki; Shiva S Forootan; Janet Adamson; Farzad S Forootan; Danqing Chen; Christopher S Foster; Philip S Rudland; Youqiang Ke
Journal:  Genes Cancer       Date:  2013-07

8.  End-binding 1 protein overexpression correlates with glioblastoma progression and sensitizes to Vinca-alkaloids in vitro and in vivo.

Authors:  Raphael Berges; Nathalie Baeza-Kallee; Emeline Tabouret; Olivier Chinot; Marie Petit; Anna Kruczynski; Dominique Figarella-Branger; Stephane Honore; Diane Braguer
Journal:  Oncotarget       Date:  2014-12-30

Review 9.  Proteome Analyses of Hepatocellular Carcinoma.

Authors:  Dominik A Megger; Wael Naboulsi; Helmut E Meyer; Barbara Sitek
Journal:  J Clin Transl Hepatol       Date:  2014-03-15

10.  TRP Channels Interactome as a Novel Therapeutic Target in Breast Cancer.

Authors:  María Paz Saldías; Diego Maureira; Octavio Orellana-Serradell; Ian Silva; Boris Lavanderos; Pablo Cruz; Camila Torres; Mónica Cáceres; Oscar Cerda
Journal:  Front Oncol       Date:  2021-06-10       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.